X0508 4 2025-01-03 false 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001450485 Lurker Nancy C/O EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET WATERTOWN MA 02472 true false false false false Common Stock 2025-01-05 4 M false 12667.00 0.00 A 110302.00 D Common Stock 2025-01-06 4 M false 75134.00 0.00 A 185436.00 D Common Stock 126889.00 I By Family Trust Stock Option (Right to Buy) 8.26 2025-01-03 4 A false 40000.00 0.00 A 2026-01-03 2035-01-03 Common Stock 40000.00 40000.00 D Restricted Stock Units 0.00 2025-01-05 4 M false 12667.00 0.00 D Common Stock 12667.00 25333.00 D Restricted Stock Units 0.00 2025-01-06 4 M false 75134.00 0.00 D Common Stock 75134.00 75133.00 D These securities are held in a trust for the benefit of the reporting person's children. The reporting person's spouse is trustee of the Family Trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The restricted stock units vests in three ratable annual installments beginning January 5, 2025. The restricted stock units vests in three ratable annual installments beginning January 6, 2024. /s/ Ron Honig, Attorney-in-Fact 2025-01-07